help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Viganò, P.
Right arrow Articles by di Blasio, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Viganò, P.
Right arrow Articles by di Blasio, A. M.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Endometriosis
The Journal of Clinical Endocrinology & Metabolism Vol. 87, No. 3 1085-1087
Copyright © 2002 by The Endocrine Society


Endocrine Care

Serum Leptin Concentrations in Endometriosis

Paola Viganò, Edgardo Somigliana, Roberta Matrone, Antonella Dubini, Carlos Barron, Mario Vignali and Anna Maria di Blasio

Istituto Auxologico Italiano, (P.V., A.D., A.M.D.) and II Department of Obstetrics and Gynecology (E.S., R.M., M.V.), University of Milan, 20135 Milan, Italy; and AREVIA GmbH (C.B.), 13353 Berlin, Germany

Address all correspondence and requests for reprints to: Dr. Anna Maria Di Blasio, Molecular Biology Laboratory, Istituto Auxologico Italiano, Viale Monte Nero 32, 20135 Milano, Italy. E-mail: . a.diblasio{at}auxologico.it

Abstract

It has been recently reported that serum concentrations of the adipocyte-derived hormone leptin are increased in patients affected by endometriosis. On the basis of these findings, the present study was undertaken to evaluate whether the protein may be used as a new serum marker of the disease. A consecutive series of 67 reproductive-age women who underwent laparoscopy for benign gynecological pathologies were enrolled prospectively for the study. Serum leptin concentrations, as evaluated by a conventional RIA kit, were related to baseline clinical characteristics and surgical and histologic diagnosis. Endometriosis was documented in 42 women (stage I–II in 19 patients and stage III–IV in 23 patients). Twenty-five women of similar age and body mass index, who had no laparoscopic evidence of the disease, served as control group. Serum levels of leptin resulted similar between women without and with endometriosis at any stage (mean ± SEM, 12.5 ± 9.4 ng/ml and 12.1 ± 8.0 ng/ml, respectively). No significant association with leptin concentrations was observed in regard to stage of the disease, number of endometriotic implants, presence/absence of an endometriotic cyst or peritoneal deep endometriosis, and presence/absence of specific symptoms. Therefore, our results do not support the possibility to employ leptin measurement as a diagnostic tool for endometriosis. Further studies are needed to elucidate the relationship between leptin and endometrial system and determine the potential contribution of the molecule in implantation and early pregnancy development.




This article has been cited by other articles:


Home page
Mol Hum ReprodHome page
I. Lima-Couy, A. Cervero, F. Bonilla-Musoles, A. Pellicer, and C. Simon
Endometrial leptin and leptin receptor expression in women with severe/moderate endometriosis
Mol. Hum. Reprod., November 1, 2004; 10(11): 777 - 782.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2002 by The Endocrine Society